{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:53:36Z","timestamp":1782294816485,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007386","name":"Pro-Reitoria de Pesquisa, Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022.1.9345.1.2"],"award-info":[{"award-number":["2022.1.9345.1.2"]}],"id":[{"id":"10.13039\/501100007386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11096-024-01787-x","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T13:03:27Z","timestamp":1723035807000},"page":"1281-1293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma"],"prefix":"10.1007","volume":"46","author":[{"given":"Ji Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taynna Tatiane","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9099-7216","authenticated-orcid":false,"given":"Inajara","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-2098","authenticated-orcid":false,"given":"T\u00e1cio de","family":"Mendon\u00e7a Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-4533","authenticated-orcid":false,"given":"Patricia Melo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-4768","authenticated-orcid":false,"given":"Mar\u00edlia Berlofa","family":"Visacri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/JCO.18.02096","volume":"37","author":"J Mikhael","year":"2019","unstructured":"Mikhael J, Ismaila N, Cheung MC, et al. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. J Clin Oncol. 2019;37:1228\u201363. https:\/\/doi.org\/10.1200\/JCO.18.02096.","journal-title":"J Clin Oncol"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.clml.2021.07.028","volume":"22","author":"R LeBlanc","year":"2022","unstructured":"LeBlanc R, Bergstrom DJ, C\u00f4t\u00e9 J, et al. Management of myeloma manifestations and complications: the cornerstone of supportive care: recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) consensus guideline consortium. Clin Lymphoma Myeloma Leuk. 2022;22:e41-56. https:\/\/doi.org\/10.1016\/j.clml.2021.07.028.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1787_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013429. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1787_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","volume":"32","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2021;32:309\u201322. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.014.","journal-title":"Ann Oncol"},{"key":"1787_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/asheducation-2017.1.508","volume":"2017","author":"P Sonneveld","year":"2017","unstructured":"Sonneveld P. Management of multiple myeloma in the relapsed\/refractory patient. Hematol Am Soc Hematol Educ Program. 2017;2017:508\u201317. https:\/\/doi.org\/10.1182\/asheducation-2017.1.508.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11899-020-00570-9","volume":"15","author":"A Guzdar","year":"2020","unstructured":"Guzdar A, Costello C. Supportive care in multiple myeloma. Curr Hematol Malig Rep. 2020;15:56\u201361. https:\/\/doi.org\/10.1007\/s11899-020-00570-9.","journal-title":"Curr Hematol Malig Rep"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/jpm12091451","volume":"12","author":"A Gozzetti","year":"2022","unstructured":"Gozzetti A, Bocchia M. Steps towards a multiple myeloma cure? J Pers Med. 2022;12:1451. https:\/\/doi.org\/10.3390\/jpm12091451.","journal-title":"J Pers Med"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016;43:676\u201381. https:\/\/doi.org\/10.1053\/j.seminoncol.2016.11.004.","journal-title":"Semin Oncol"},{"key":"1787_CR9","unstructured":"National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. 2023. https:\/\/seer.cancer.gov\/explorer\/. Accessed 05 Jun 2023."},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"151173","DOI":"10.1016\/j.soncn.2021.151173","volume":"37","author":"M Ebied","year":"2021","unstructured":"Ebied M, Chan V. Multidisciplinary professional roles addressing needs in multiple myeloma: an innovative \u201cvirtual\u201d pharmacist surveillance clinic. Semin Oncol Nurs. https:\/\/doi.org\/10.1016\/j.soncn.2021.151173","journal-title":"Semin Oncol Nurs"},{"key":"1787_CR11","unstructured":"Leukaemia Foundation and Australian Government Department of Health. Optimal care pathway for people with multiple myeloma. 2021. https:\/\/www.cancer.org.au\/assets\/pdf\/multiple-myeloma-1st-edition. Accessed 29 Jun 2024."},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1078155215572036","volume":"22","author":"E Ashjian","year":"2016","unstructured":"Ashjian E, Redic K. Multiple myeloma: updates for pharmacists in the treatment of relapsed and refractory disease. J Oncol Pharm Pract. 2016;22:289\u2013302. https:\/\/doi.org\/10.1177\/1078155215572036.","journal-title":"J Oncol Pharm Pract"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2146\/ajhp160244","volume":"73","author":"CM Herndon","year":"2016","unstructured":"Herndon CM, Nee D, Atayee RS, et al. ASHP guidelines on the pharmacist\u2019s role in palliative and hospice care. Am J Health Syst Pharm. 2016;73:1351\u201367. https:\/\/doi.org\/10.2146\/ajhp160244.","journal-title":"Am J Health Syst Pharm"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11096-023-01535-7","volume":"45","author":"U Wernli","year":"2023","unstructured":"Wernli U, Hischier D, Meier CR, et al. Pharmacists\u2019 clinical roles and activities in inpatient hospice and palliative care: a scoping review. Int J Clin Pharm. 2023;45:577\u201386. https:\/\/doi.org\/10.1007\/s11096-023-01535-7.","journal-title":"Int J Clin Pharm"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jep.12339","volume":"21","author":"I Rotta","year":"2015","unstructured":"Rotta I, Salgado TM, Felix DC, et al. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21:584\u201390. https:\/\/doi.org\/10.1111\/jep.12339.","journal-title":"J Eval Clin Pract"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.4065\/83.10.1131","volume":"83","author":"MA Gertz","year":"2008","unstructured":"Gertz MA, Ansell SM, Dingli D, et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc. 2008;83:1131\u20138. https:\/\/doi.org\/10.4065\/83.10.1131.","journal-title":"Mayo Clin Proc"},{"key":"1787_CR19","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2146\/news150084","volume":"72","author":"K Traynor","year":"2015","unstructured":"Traynor K. Advanced pharmacy services support multiple myeloma clinic. Am J Health Syst Pharm. 2015;72:2125\u201332. https:\/\/doi.org\/10.2146\/news150084.","journal-title":"Am J Health Syst Pharm"},{"key":"1787_CR20","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1200\/JOP.18.00085","volume":"14","author":"K Sweiss","year":"2018","unstructured":"Sweiss K, Wirth SM, Sharp L, et al. Collaborative physician-pharmacist-managed multiple myeloma clinic improves guideline adherence and prevents treatment delays. J Oncol Pract. 2018;14:e674\u201382. https:\/\/doi.org\/10.1200\/JOP.18.00085.","journal-title":"J Oncol Pract"},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.18553\/jmcp.2019.25.11.1244","volume":"25","author":"J Mauro","year":"2019","unstructured":"Mauro J, Mathews KB, Sredzinski ES. Effect of a smart pill bottle and pharmacist intervention on medication adherence in patients with multiple myeloma new to lenalidomide therapy. J Manag Care Spec Pharm. 2019;25:1244\u201354. https:\/\/doi.org\/10.18553\/jmcp.2019.25.11.1244.","journal-title":"J Manag Care Spec Pharm"},{"key":"1787_CR22","doi-asserted-by":"publisher","first-page":"e0243309","DOI":"10.1371\/journal.pone.0243309","volume":"15","author":"J P\u00e9richou","year":"2020","unstructured":"P\u00e9richou J, Ranchon F, Herledan C, et al. Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients\u2019 knowledge to manage adverse effects. PLoS ONE. 2020;15:e0243309. https:\/\/doi.org\/10.1371\/journal.pone.0243309.","journal-title":"PLoS ONE"},{"key":"1787_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/1078155219851550","volume":"26","author":"K Sweiss","year":"2020","unstructured":"Sweiss K, Calip GS, Wirth S, et al. Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician-pharmacist clinic. J Oncol Pharm Pract. 2020;26:536\u201342. https:\/\/doi.org\/10.1177\/1078155219851550.","journal-title":"J Oncol Pharm Pract"},{"key":"1787_CR24","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/j.clml.2020.04.012","volume":"20","author":"A Virani","year":"2020","unstructured":"Virani A, Schlei Z, Gleason C, et al. Impact of an oncology clinical pharmacist specialist in an outpatient multiple myeloma clinic. Clin Lymphoma Myeloma Leuk. 2020;20:e543\u20136. https:\/\/doi.org\/10.1016\/j.clml.2020.04.012.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1787_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/1078155221995885","volume":"28","author":"A Parnes","year":"2022","unstructured":"Parnes A, Leblebjian H, Hamilton J, et al. Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system. J Oncol Pharm Pract. 2022;28:421\u20134. https:\/\/doi.org\/10.1177\/1078155221995885.","journal-title":"J Oncol Pharm Pract"},{"key":"1787_CR26","doi-asserted-by":"publisher","first-page":"101680","DOI":"10.1016\/j.jgo.2023.101680","volume":"15","author":"CE Jensen","year":"2024","unstructured":"Jensen CE, Deal AM, Nyrop KA, et al. Geriatric assessment-guided interventions for older adults with multiple myeloma: a feasibility and acceptability study. J Geriatr Oncol. 2024;15:101680. https:\/\/doi.org\/10.1016\/j.jgo.2023.101680.","journal-title":"J Geriatr Oncol"},{"key":"1787_CR27","doi-asserted-by":"publisher","first-page":"101974","DOI":"10.1016\/j.ejon.2021.101974","volume":"52","author":"HJ Dunnack","year":"2021","unstructured":"Dunnack HJ, Montano AL. Interprofessional clinical pathway program effects on patient outcomes in the setting of neutropenic fever: an integrative review. Eur J Oncol Nurs. 2021;52:101974. https:\/\/doi.org\/10.1016\/j.ejon.2021.101974.","journal-title":"Eur J Oncol Nurs"},{"key":"1787_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/JHQ.0000000000000039","volume":"39","author":"S Ashcraft","year":"2017","unstructured":"Ashcraft S, Bordelon C, Fells S, et al. Interprofessional clinical rounding: effects on processes and outcomes of care. J Healthc Qual. 2017;39:85\u201394. https:\/\/doi.org\/10.1097\/JHQ.0000000000000039.","journal-title":"J Healthc Qual"},{"key":"1787_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24926\/iip.v14i2.5114","volume":"14","author":"V Lam","year":"2023","unstructured":"Lam V, Dimaculangan C. Impact of an interdisciplinary patient care model and routine screening on clinical outcomes in patients with hepatitis C. Innov Pharm. 2023;14:1\u20138. https:\/\/doi.org\/10.24926\/iip.v14i2.5114.","journal-title":"Innov Pharm"},{"key":"1787_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.japh.2021.10.031","volume":"62","author":"CM Polomoff","year":"2022","unstructured":"Polomoff CM, Bermudez-Millan A, Buckley T, et al. Pharmacists and community health workers improve medication-related process outcomes among Cambodian Americans with depression and risk for diabetes. J Am Pharm Assoc. 2022;62:496-504.e1. https:\/\/doi.org\/10.1016\/j.japh.2021.10.031.","journal-title":"J Am Pharm Assoc"},{"key":"1787_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.japh.2020.11.024","volume":"61","author":"BE Lott","year":"2021","unstructured":"Lott BE, Anderson EJ, Villa Zapata L, et al. Expanding pharmacists\u2019 roles: pharmacists\u2019 perspectives on barriers and facilitators to collaborative practice. J Am Pharm Assoc. 2021;61:213-20.e1. https:\/\/doi.org\/10.1016\/j.japh.2020.11.024.","journal-title":"J Am Pharm Assoc"},{"key":"1787_CR32","doi-asserted-by":"publisher","first-page":"141.e1","DOI":"10.5694\/mja2.50461","volume":"212","author":"L Kouladjian O'Donnell","year":"2020","unstructured":"Kouladjian O\u2019Donnell L, Sawan MJ. Deprescribing needs to be considered in the pharmacists\u2019 prescribing role. Med J Aust. 2020;212:141.e1. https:\/\/doi.org\/10.5694\/mja2.50461.","journal-title":"Med J Aust"},{"key":"1787_CR33","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.3390\/healthcare11243106","volume":"11","author":"A Owczarek","year":"2023","unstructured":"Owczarek A, Marciniak DM, Jezior R, et al. Assessment of the prescribing pharmacist\u2019s role in supporting access to prescription-only medicines-metadata analysis in Poland. Healthcare (Basel). 2023;11:3106. https:\/\/doi.org\/10.3390\/healthcare11243106.","journal-title":"Healthcare (Basel)"},{"key":"1787_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40264-016-0501-2","volume":"40","author":"NA Brandenburg","year":"2017","unstructured":"Brandenburg NA, Bwire R, Freeman J, et al. Effectiveness of risk evaluation and mitigation strategies (REMS) for lenalidomide and thalidomide: patient comprehension and knowledge retention. Drug Saf. 2017;40:333\u201341. https:\/\/doi.org\/10.1007\/s40264-016-0501-2.","journal-title":"Drug Saf"},{"key":"1787_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1310\/hpj5009-834","volume":"50","author":"B Shay","year":"2015","unstructured":"Shay B, Louden L, Kirschenbaum B. Specialty pharmacy services: preparing for a new era in health-system pharmacy. Hosp Pharm. 2015;50:834\u20139. https:\/\/doi.org\/10.1310\/hpj5009-834.","journal-title":"Hosp Pharm"},{"key":"1787_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.japh.2019.07.008","volume":"59","author":"PG Clay","year":"2019","unstructured":"Clay PG, Burns AL, Isetts BJ, et al. PaCIR: a tool to enhance pharmacist patient care intervention reporting. J Am Pharm Assoc. 2019;59:615\u201323. https:\/\/doi.org\/10.1016\/j.japh.2019.07.008.","journal-title":"J Am Pharm Assoc"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01787-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:08:53Z","timestamp":1732068533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01787-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01787-x","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}